Gestational doxorubicin alters fetal thyroid–brain axis
Authors:
- 23 November 2012
- journal article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 31 (2) , 96-104
Abstract
Administration of chemotherapy during pregnancy may represent a big risk factor for the developing brain, therefore we studied whether the transplacental transport of doxorubicin (DOX) may affect the development of neuroendocrine system. DOX (25 mg/kg; 3 times interaperitoneally/week) was given to pregnant rats during whole gestation period. The disturbances in neuroendocrine functions were investigated at gestation day (GD) 15 and 20 by following the maternal and fetal thyroid hormone levels, fetal nucleotides (ATP, ADP, AMP) levels and adenosine triphosphatase (Na+, K+‐ATPase, Ca2+‐ATPase and Mg2+‐ATPase) activities in two brain regions, cerebrum and cerebellum. In control group, the levels of maternal and fetal serum thyroxine (T4), triiodothyronine (T3), thyrotropin (TSH), and fetal serum growth hormone (GH) increased from days 15 to 20, whereas in the DOX group, a decrease in maternal and fetal T4, T3 and increase in TSH levels (hypothyroid status) were observed. Also, the levels of fetal GH decreased continuously from GD 15 to 20 with respect to control group. In cerebrum and cerebellum, the levels of fetal nucleotides and the activities of fetal ATPases in control group followed a synchronized course of development. The fetal hypothyroidism due to maternal administration of DOX decreased the levels of nucleotides, ATPases activities, and total adenylate, instead, the adenylate energy charge showed a trend to an increase in both brain regions at all ages tested. These alterations were dose‐ and age‐dependent and this, in turn, may impair the nerve transmission. Finally, DOX may act as neuroendocrine disruptor causing hypothyroidism and fetal brain energetic dysfunction.Keywords
Funding Information
- Italian Ministry for Education, University and Research
- General Management for International Research
This publication has 84 references indexed in Scilit:
- Doxorubicin pathwaysPharmacogenetics and Genomics, 2011
- Analysis of proteome changes in doxorubicin-treated adult rat cardiomyocyteJournal of Proteomics, 2011
- The natural history of thyroid function abnormalities after treatment for childhood cancerEuropean Journal of Cancer, 2007
- Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfallsCell Biology and Toxicology, 2006
- Short-Term Effects of Thyroid Hormones on Cytoskeletal Proteins Are Mediated by GABAergic Mechanisms in Slices of Cerebral Cortex from Young RatsCellular and Molecular Neurobiology, 2006
- Involvement of calcium-dependent mechanisms in T3-induced phosphorylation of vimentin of immature rat testisLife Sciences, 2005
- ATP and ADP hydrolysis in brain membranes of zebrafish (Danio rerio)Life Sciences, 2003
- Activation of A3Adenosine Receptor Protects Against Doxorubicin-induced CardiotoxicityJournal of Molecular and Cellular Cardiology, 2001
- Teratogenic effects of Doxorubicin in rats at midgestation and at termTeratogenesis, Carcinogenesis, and Mutagenesis, 2001
- The cardiotoxic antibiotic doxorubicin inhibits the Na+/Ca2+ exchange of dog heart sarcolemmal vesiclesFEBS Letters, 1981